- Products & Solutions
- FDA IVD
- About Us
- News & Events
- Contact
- Additional Sites
The Quantum Blue® fCAL lateral flow assay combines the ease and speed of lateral flow technology (using a highly specific monoclonal antibody to calprotectin), with full quantification by means of a small, telephone sized reading device and the result is obtained within 12-15 minutes. The Quantum Blue® Reader analyzes the signal intensity from the test and control line to give a quantitative value and is standardized with the BÜHLMANN fCAL® ELISA.
The BÜHLMANN Quantum Blue® Infliximab is the first rapid test to measure infliximab in serum samples. The test is designed for the selective measurement of infliximab by a sandwich immunoassay and provides a quantitative result within 15 minutes. Quantum Blue® Infliximab is unique, being the ONLY test that can provide fast, reliable information for infliximab, and correlating well with the standard routine ELISAs for determination of infliximab levels.
The BÜHLMANN Quantum Blue® Adalimumab is the ONLY rapid test to measure adalimumab in serum samples. The test is designed for the selective measurement of adalimumab by a sandwich immunoassay. Quantum Blue® Adalimumab is unique in the market, being the ONLY test that can provide fast, reliable information for adalimumab and it correlates well with the standard routine ELISAs for adalimumab level determinations.
The Quantum Blue® hsCRP lateral flow assay is designed for the quantitative determination of CRP in human serum in combination with the BÜHLMANN Quantum Blue® Reader. Less than 50 µl serum is required to perform the lateral flow test for CRP. The intended use of Quantum Blue ® hsCRP is for the study of irritable bowel disease (IBD) related research.
Quantum Blue® Reader 3rd Generation-
• BI-POCTR-ABS- Reader User Manual [EN]
• Quick Guide – Fail Safe Mode [EN]
• Quick Guide – Fast Track Mode [EN]
Quantum Blue® Reader 2nd Generation User Manual-
• BI-POCTR-ABS- Reader User Manual [EN]
• BI-POCTR-ABS- Reader User Manual [FR]
Related Quantum Blue® assays:
Quantum Blue® fCAL High Range – LF-CHR25-U
Quantum Blue® fCAL extended – LF-CALE25-U
BÜHLMANN Quantum Blue® Adalimumab – LF-TLAD25-U/LF-TLAD10-U
BÜHLMANN Quantum Blue® Anti-Adalimumab – LF-ADAD25-U/LF-ADAD10-U
BÜHLMANN Quantum Blue® Infliximab – LF-TLIF25-U/LF-TLIF10-U
BÜHLMANN Quantum Blue® Anti-Infliximab – LF-ADIF25-U/LF-ADIF10-U
Quantum Blue® Reader 3rd Generation-
• BI-POCTR-ABS- Reader User Manual [EN]
• Quick Guide – Fail Safe Mode [EN]
• Quick Guide – Fast Track Mode [EN]
Quantum Blue® Reader 2nd Generation User Manual-
• BI-POCTR-ABS- Reader User Manual [EN]
• BI-POCTR-ABS- Reader User Manual [FR]
Related Quantum Blue® assays:
Quantum Blue® fCAL High Range – LF-CHR25
Quantum Blue® fCAL extended – LF-CALE25
BÜHLMANN Quantum Blue® Adalimumab – LF-TLAD25/LF-TLAD10
BÜHLMANN Quantum Blue® Anti-Adalimumab – LF-ADAD25-U/LF-ADAD10-U
BÜHLMANN Quantum Blue® Infliximab – LF-TLIF25/LF-TLIF10
BÜHLMANN Quantum Blue® Anti-Infliximab – LF-ADIF25/LF-ADIF10